FI119059B - Lactobacillus-stammar av människoursprung, deras sammansättningar och deras användningar - Google Patents

Lactobacillus-stammar av människoursprung, deras sammansättningar och deras användningar Download PDF

Info

Publication number
FI119059B
FI119059B FI964681A FI964681A FI119059B FI 119059 B FI119059 B FI 119059B FI 964681 A FI964681 A FI 964681A FI 964681 A FI964681 A FI 964681A FI 119059 B FI119059 B FI 119059B
Authority
FI
Finland
Prior art keywords
cncm
strains
lactobacillus
atcc
lactobacilli
Prior art date
Application number
FI964681A
Other languages
English (en)
Finnish (fi)
Other versions
FI964681A (sv
FI964681A0 (sv
Inventor
Haen Christoph De
Lorenzo Morelli
Vittorio Bottazzi
Luigia Gozzini
Original Assignee
Bracco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26331139&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI119059(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from ITMI941073A external-priority patent/IT1269838B/it
Priority claimed from ITMI941773A external-priority patent/IT1274733B/it
Application filed by Bracco Spa filed Critical Bracco Spa
Publication of FI964681A0 publication Critical patent/FI964681A0/sv
Publication of FI964681A publication Critical patent/FI964681A/sv
Application granted granted Critical
Publication of FI119059B publication Critical patent/FI119059B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Claims (12)

1. Stammar av Lactobacillus, vilka är deponerade vid CNCM-kollektionen av paste-ur-institutet med numren 1-1390,1-1391,1-1392 och 1-1447. 5
2. Farmaceutiska, veterinärmedicinska eller näringssammansättningar, k ä n n e -tecknade därav, att de innefattar ätminstone en av Lactobacillusstammama I-1390,1-1391,1-1392 och 1-1447 enligt patentkrav 1, i blandning med ett kompatibelt transportämne. 10
3. Farmaceutiska, veterinärmedicinska eller näringssammansättningar, känne-tecknade därav, att de innefattar en eller flera av Lactobacillusstammama enligt patentkrav 1, i blandning med andra stammar med kompletterande egenskaper.
4. Farmaceutiska, veterinärmedicinska eller näringssammansättningar, känne- tecknade därav, att i dem hör ätminstone en av stammama till Lactobacillus acidophilus arten, och ätminstone en hör till en icke-acidophilusart.
*·**· 5. Sammansättningar enligt patentkrav 2, kännetecknade därav, att de inne- :.V 20 häller en blandning av alla stammama 1-1390,1-1391,1-1392 och 1-1447. • · · • 1 · «·· • · · •••i
6. Sammansättningar enligt patentkrav 2, kännetecknade därav, att stam- *·ϊ·1 mama 1-1390 och/eller 1-1391 och/eller 1-1392 och/eller 1-1447 är närvarande i lyofi- ·· • · · liseradfonn. 25 • · · I.;
7. Sammansättningar enligt nägot av patentkraven 2—6, kännetecknade • · *11 därav, att de är i form av kapslar, lösningar eller drickbara suspensioner eller pulver i »· · • · · * ·1 portionspäsar. ··· · • · ··· ·· · • · · • · • φ · · • · • · ·«1 „ 119059
8. Sammansättningar enligt nägot av patentkraven 2—7, kännetecknade därav, att de innehäller frän 106—1010 celler av var och en individuell stam per en-hetsdos.
9. Användningen av Lactobacillusstammama enligt patentkrav 1 för framställning av läkemedel som är användbara för behandling eller förebyggande av patologiska till-ständ i matsmältningskanalen, i vilka administration av laktobaciller är önskvärt.
10. Användningen enligt patentkrav 9 för framställning av läkemedel för behandling 10 eller förebyggande av mikrobbalans i tarmama, diarreer av olika ursprung eller särig tj ocktarmsinflammation.
11. Användningen av Lactobacillusstammama enligt patentkrav 1 för framställning av läkemedel som är användbara för behandling av nyfödda i alla situationer av 15 ofördelaktig kolonisation i matsmältningskanalen.
12. Användningen av Lactobacillusstammama enligt patentkrav 1 för framställning av mejeriprodukter som är avsedda att användas som livsmedel. • 1 0.': 20 • · · • · · • · · ··· *··» • · • » t ««· « · · • « · • · · • · * 1 « • · · • · • · • · · • · · • · • · • · • » • · 1 • · · • · • · · • · ··#
FI964681A 1994-05-26 1996-11-25 Lactobacillus-stammar av människoursprung, deras sammansättningar och deras användningar FI119059B (sv)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
ITMI941073 1994-05-26
ITMI941073A IT1269838B (it) 1994-05-26 1994-05-26 Ceppi di lattobacilli di origine umana e loro usi
ITMI941773 1994-08-25
ITMI941773A IT1274733B (it) 1994-08-25 1994-08-25 Ceppo del genere lactobacillus di origine umana e suoi usi
EP9501886 1995-05-18
PCT/EP1995/001886 WO1995033046A1 (en) 1994-05-26 1995-05-18 Lactobacillus strains of human origin, their compositions and uses thereof

Publications (3)

Publication Number Publication Date
FI964681A0 FI964681A0 (sv) 1996-11-25
FI964681A FI964681A (sv) 1997-01-08
FI119059B true FI119059B (sv) 2008-07-15

Family

ID=26331139

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964681A FI119059B (sv) 1994-05-26 1996-11-25 Lactobacillus-stammar av människoursprung, deras sammansättningar och deras användningar

Country Status (18)

Country Link
US (1) US5709857A (sv)
EP (1) EP0760848B1 (sv)
JP (1) JP3653277B2 (sv)
CN (1) CN1094972C (sv)
AT (1) ATE163042T1 (sv)
AU (1) AU686389B2 (sv)
BR (1) BR9507752A (sv)
CA (1) CA2191213C (sv)
DE (2) DE69501591T2 (sv)
DK (1) DK0760848T3 (sv)
ES (1) ES2099056T3 (sv)
FI (1) FI119059B (sv)
GR (2) GR970300016T1 (sv)
HU (1) HU220190B (sv)
MX (1) MX9605807A (sv)
NO (1) NO316644B1 (sv)
NZ (1) NZ287420A (sv)
WO (1) WO1995033046A1 (sv)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN175495A0 (en) * 1995-03-14 1995-04-13 University Of New England, The Method and composition for the prevention of the over production of acid
AUPN698495A0 (en) * 1995-12-06 1996-01-04 Pharma Pacific Pty Ltd Improved therapeutic formulation and method
IT1289159B1 (it) * 1997-01-08 1998-09-29 Yurta S R L Composizioni farmaceutiche e alimentari a base di batteri del genere acetobacter
IT1289984B1 (it) * 1997-02-27 1998-10-19 Proge Farm Srl Ceppi di lattobacilli utili nel trattamento di disfunzioni del sistema gastrointestinale
IT1299070B1 (it) * 1998-04-10 2000-02-07 Proge Farm Srl Ceppi di lattobacilli capaci di inibire e/o avere azione microbicida nei confronti di microorganismi patogeni e metodo di induzione e
US7202219B1 (en) * 1998-02-24 2007-04-10 Md Foods Amba Use of D-tagatose as a prebiotic food component
EP0956858B1 (en) * 1998-04-30 2001-10-31 Renata Maria Anna Cavaliere Vesely Pharmaceutical compositions containing Lactobacillus brevis and Lactobacillus salivarius for treatment of vaginal infections
US7029702B2 (en) * 1998-07-07 2006-04-18 Ritter Natural Sciences Llc Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
US6080401A (en) * 1998-11-19 2000-06-27 Reddy; Malireddy S. Herbal and pharmaceutical drugs enhanced with probiotics
BR0008920A (pt) 1999-03-11 2001-12-18 Nestle Sa Cepas de lactobacillus capazes de prevenirdiarréia causada por bactéria patogênica erotaviroses
EP1034787A1 (en) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
EP1034788A1 (en) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactic acid bacteria strains capable of preventing diarrhea
US20040105848A1 (en) * 1999-04-30 2004-06-03 Natarajan Ranganathan Enteric dialysis compositions and methods
US6696057B1 (en) 1999-09-22 2004-02-24 Lacpro Industries, Inc. Composition and method for treatment of gastrointestinal disorders and hyperlipidemia
US20040166101A1 (en) * 1999-09-22 2004-08-26 Bojrab Gregory G. Enchanced composition for treatment of gastrointestinal disorders and hyperlipidemia
US6641808B1 (en) * 1999-09-22 2003-11-04 Lacpro Industries, Llc Composition for treatment of obesity
US6613549B2 (en) 2000-02-10 2003-09-02 Urex Biotech, Inc. Probiotic therapy for newborns
ATE419880T1 (de) * 2000-06-09 2009-01-15 Baylor College Medicine Kombination von antimikrobiellen wirkstoffen und bakterieller interferenz zum überziehen medizinischer vorrichtungen
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
BR0116349A (pt) 2000-12-18 2003-12-23 Probiohealth Llc Compostos probióticos derivados da cepa ke01 de lactobacillus casei
US7214370B2 (en) * 2000-12-18 2007-05-08 Probiohealth, Llc Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
US7060687B2 (en) * 2001-02-07 2006-06-13 Genmont Biotechnology Co. Live vaccines for allergy treatment
NO318426B1 (no) * 2001-10-02 2005-04-18 Neurozym Biotech As Et materiale for a senke konsentrasjonen av patogene tarmpeptider
US8147821B2 (en) 2002-02-21 2012-04-03 Grain Processing Corporation Method for drying biomaterials
RU2316586C2 (ru) 2002-03-21 2008-02-10 Бифодан А/С ПРОБИОТИЧЕСКИЕ ШТАММЫ Lactobacillus (ВАРИАНТЫ) И ИХ ПРИМЕНЕНИЕ
WO2006012536A2 (en) * 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
CA2547144C (en) 2005-05-16 2010-02-02 Grain Processing Corporation Method for drying spent filter media
CN101273738B (zh) * 2007-03-28 2011-06-01 哈尔滨正方科技有限公司 在常温下保持高活菌数的调配型酸性乳饮料的制备方法
PL2016834T3 (pl) * 2007-07-13 2010-04-30 Unilever Nv Produkt żywnościowy zawierający bakterie i sorbitolowy ester kwasu tłuszczowego
US20090041727A1 (en) * 2007-08-08 2009-02-12 Conjugon, Inc. Compositions and Methods for Microbe Storage and Delivery
US20110223248A1 (en) * 2007-12-12 2011-09-15 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance
US20110189148A1 (en) * 2008-06-25 2011-08-04 Ritter Pharmaceuticals, Inc. Lactose compositions with decreased lactose content
KR101003149B1 (ko) * 2008-10-31 2010-12-22 전남대학교산학협력단 병변 치료용 박테리아 기반의 마이크로로봇
EP2206506A1 (en) 2008-12-18 2010-07-14 Bracco Imaging S.p.A Probiotic formulations
US8785160B2 (en) 2009-02-24 2014-07-22 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
CA2752800C (en) 2009-02-24 2017-12-05 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
EP2248908A1 (en) 2009-05-05 2010-11-10 Eurolactis Group S.A. Probiotic microorganisms isolated from donkey milk
US20120087902A1 (en) * 2009-07-20 2012-04-12 Bracco S.P.A. Therapeutic Use Of Probiotics
CN103124559B (zh) 2010-08-04 2017-03-29 托马斯·朱利叶斯·波洛迪 用于粪便菌群植入的组合物及其制备和使用方法以及递送该组合物的装置
CA3119918A1 (en) 2011-03-09 2012-09-13 Regents Of The University Of Minnesota Compositions and methods for transplantation of colon microbiota
WO2013176774A1 (en) 2012-05-25 2013-11-28 Arizona Board Of Regents Microbiome markers and therapies for autism spectrum disorders
DK2900805T3 (da) 2012-09-25 2023-02-27 Aquilon Cyl S L Sanidad Animal Probiotiske og præbiotiske sammensætninger
EP3294307A4 (en) 2015-05-14 2019-01-23 Crestovo Holdings Llc COMPOSITIONS FOR TRANSPLANTATION OF FECAL FLORA AND METHODS OF PREPARATION AND USE THEREOF, AND DEVICES FOR THEIR ADMINISTRATION
CA2986485A1 (en) 2015-05-22 2016-12-01 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US20170360848A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US10849936B2 (en) 2016-07-01 2020-12-01 Regents Of The University Of Minnesota Compositions and methods for C. difficile treatment
US20180036352A1 (en) 2016-08-03 2018-02-08 Crestovo Holdings Llc Methods for treating ulcerative colitis
US11026978B2 (en) 2016-10-11 2021-06-08 Finch Therapeutics Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
WO2018071536A1 (en) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating primary sclerosing cholangitis and related disorders
US10092601B2 (en) 2016-10-11 2018-10-09 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
US11433102B2 (en) 2017-04-05 2022-09-06 Finch Therapeutics Holdings Llc Compositions and methods for treating Parkinson's disease (PD) and related disorders
US11040073B2 (en) 2017-04-05 2021-06-22 Finch Therapeutics Holdings Llc Compositions and methods for treating diverticulitis and related disorders
WO2018218159A1 (en) 2017-05-26 2018-11-29 Crestovo Holdings Llc Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same
EP3664823B1 (en) 2017-08-07 2024-06-05 Finch Therapeutics Holdings LLC Composition for use in preventing or treating an enterococcal blood stream infection
US11166990B2 (en) 2018-07-13 2021-11-09 Finch Therapeutics Holdings Llc Methods and compositions for treating ulcerative colitis
CA3114423A1 (en) 2018-09-27 2020-04-02 Finch Therapeutics Holdings Llc Compositions and methods for treating epilepsy and related disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
US4946791A (en) * 1986-10-02 1990-08-07 Bio Techniques Laboratories, Inc. Novel strain of Lactobacillus acidophilus
US5179020A (en) * 1991-08-19 1993-01-12 Bio Techniques Laboratories, Inc. Antibiotic resistant strain of lactobacillus acidophilus
ES2124060T5 (es) * 1992-07-06 2002-12-16 Nestle Sa Bacteria lactica.

Also Published As

Publication number Publication date
EP0760848B1 (en) 1998-02-04
EP0760848A1 (en) 1997-03-12
NO964966L (no) 1997-01-23
JP3653277B2 (ja) 2005-05-25
CN1094972C (zh) 2002-11-27
BR9507752A (pt) 1997-10-07
DE69501591T2 (de) 1998-06-10
US5709857A (en) 1998-01-20
MX9605807A (es) 1997-12-31
HU220190B (hu) 2001-11-28
WO1995033046A1 (en) 1995-12-07
ES2099056T1 (es) 1997-05-16
DE760848T1 (de) 1997-08-28
JPH10500577A (ja) 1998-01-20
CN1154715A (zh) 1997-07-16
AU2613995A (en) 1995-12-21
ES2099056T3 (es) 1998-04-01
NO964966D0 (no) 1996-11-22
NZ287420A (en) 1997-12-19
AU686389B2 (en) 1998-02-05
FI964681A (sv) 1997-01-08
GR3026758T3 (en) 1998-07-31
DK0760848T3 (da) 1998-09-23
FI964681A0 (sv) 1996-11-25
CA2191213C (en) 2008-03-18
HUT75555A (en) 1997-05-28
CA2191213A1 (en) 1995-12-07
DE69501591D1 (de) 1998-03-12
ATE163042T1 (de) 1998-02-15
NO316644B1 (no) 2004-03-22
HU9603251D0 (en) 1997-01-28
GR970300016T1 (en) 1997-05-31

Similar Documents

Publication Publication Date Title
FI119059B (sv) Lactobacillus-stammar av människoursprung, deras sammansättningar och deras användningar
JP4350170B2 (ja) ラクトバチルス・カセイ・ラムノススを含む薬学的調製物
KR100386144B1 (ko) 헬리코박터 파일로리 （Ｈｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉ）제균성 식음료 제품
HU218350B (hu) A bél és/vagy gyomorsejtekről a Helicobacter pylorit leszárítani képes CNCM I-1225 törzs tenyészetéből származó felülúszó fázis és ezt, vagy a törzs tenyészetét tartalmazó élelmiszer- és gyógyszerkészítmények
EP0154549A2 (en) Anticariogenic or antiperiodontitic agent
EP1802318A1 (en) Lactic acid bacteria strains useful against gastrointestinal pathogens and compositions containing same
JPS62145026A (ja) 抗発癌剤
WO2008077229A1 (en) Growth inhibition of microorganisms by lactic acid bacteria
US20070134220A1 (en) Lactobacillus fermentum strain and uses thereof
JP2006508943A (ja) 酵母成長を阻害するための方法
ES2296635T3 (es) Bifidobacteria capaz de prevenir la diarrea.
Romond et al. Cell-free wheys from bifidobacteria fermented milks exert a regulatory effect on the intestinal microflora of mice and humans
US20230201280A1 (en) Methods for improving gastrointestinal barrier function and inhibiting growth of enteric pathogenic bacteria
US20030077255A1 (en) Compositions of bacteria and alpha-lactalbumin and uses thereof
US20230031534A1 (en) Methods for alleviating enteric pathogenic bacterium-associated disorder and inhibiting growth of enteric pathogenic bacteria
JP2001002578A (ja) Ｈｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉ除菌性医薬品
JP2012147759A (ja) ヘリコバクター・ピロリ及びその他の病原菌を抑制するラクトバシラス属乳酸菌を含有する新規納豆
US11896632B2 (en) Methods for inhibiting growth of oral pathogenic bacteria and alleviating oral pathogenic bacteria-associated disorder
Fauziah et al. Effects of Lactobacillus bulgaricus in soyghurt on inhibition of adhesion Klebsiella pneumoniae strains in HEp-2 cell lines.
Suresh et al. Antibacterial Activity of Lactobacillus (LB) Strains Isolated from Goat Milk against ESBL Producing E. coli Causing Wound Infections.
Hoseinian et al. Lactobacillus spp. Inhibit the Biofilm Formation of Pseudomonas aeruginosa
KR100845034B1 (ko) 충치균 성장을 억제하는 항균제를 생성하는 락토바실루스파라플란타룸 ｋｎｕｃ25로부터 제조된 충치균 항균제
ITMI941073A1 (it) Ceppi di lattobacilli di origine umana e loro usi
ITMI941773A1 (it) Ceppo del genere lactobacillus di origine umana e suoi usi

Legal Events

Date Code Title Description
MM Patent lapsed